vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and 1ST SOURCE CORP (SRCE). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $113.1M, roughly 1.8× 1ST SOURCE CORP). 1ST SOURCE CORP runs the higher net margin — 35.3% vs 2.7%, a 32.6% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 8.7%). 1ST SOURCE CORP produced more free cash flow last quarter ($58.1M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 7.8%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

1st Source Corporation is a financial services company headquartered in South Bend, Indiana. It operates 1st Source Bank, a bank with 81 branches in Indiana and Michigan. The bank's Specialty Finance Group provides financing for aircraft, trucks, and construction equipment. 1st Source Insurance provides insurance products and services.

IRTC vs SRCE — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.8× larger
IRTC
$208.9M
$113.1M
SRCE
Growing faster (revenue YoY)
IRTC
IRTC
+18.4% gap
IRTC
27.1%
8.7%
SRCE
Higher net margin
SRCE
SRCE
32.6% more per $
SRCE
35.3%
2.7%
IRTC
More free cash flow
SRCE
SRCE
$43.6M more FCF
SRCE
$58.1M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
7.8%
SRCE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRTC
IRTC
SRCE
SRCE
Revenue
$208.9M
$113.1M
Net Profit
$5.6M
$40.0M
Gross Margin
70.9%
Operating Margin
1.1%
45.4%
Net Margin
2.7%
35.3%
Revenue YoY
27.1%
8.7%
Net Profit YoY
518.5%
6.5%
EPS (diluted)
$0.18
$1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
SRCE
SRCE
Q1 26
$113.1M
Q4 25
$208.9M
$110.8M
Q3 25
$192.9M
$110.7M
Q2 25
$186.7M
$108.2M
Q1 25
$158.7M
$104.0M
Q4 24
$164.3M
$97.8M
Q3 24
$147.5M
$97.9M
Q2 24
$148.0M
$97.3M
Net Profit
IRTC
IRTC
SRCE
SRCE
Q1 26
$40.0M
Q4 25
$5.6M
$41.1M
Q3 25
$-5.2M
$42.3M
Q2 25
$-14.2M
$37.3M
Q1 25
$-30.7M
$37.5M
Q4 24
$-1.3M
$31.4M
Q3 24
$-46.2M
$34.9M
Q2 24
$-20.1M
$36.8M
Gross Margin
IRTC
IRTC
SRCE
SRCE
Q1 26
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Operating Margin
IRTC
IRTC
SRCE
SRCE
Q1 26
45.4%
Q4 25
1.1%
Q3 25
-4.4%
49.7%
Q2 25
-10.0%
44.5%
Q1 25
-20.5%
45.8%
Q4 24
-2.5%
Q3 24
-34.1%
46.3%
Q2 24
-15.5%
49.1%
Net Margin
IRTC
IRTC
SRCE
SRCE
Q1 26
35.3%
Q4 25
2.7%
37.1%
Q3 25
-2.7%
38.2%
Q2 25
-7.6%
34.5%
Q1 25
-19.3%
36.1%
Q4 24
-0.8%
32.1%
Q3 24
-31.3%
35.7%
Q2 24
-13.6%
37.8%
EPS (diluted)
IRTC
IRTC
SRCE
SRCE
Q1 26
$1.63
Q4 25
$0.18
$1.67
Q3 25
$-0.16
$1.71
Q2 25
$-0.44
$1.51
Q1 25
$-0.97
$1.52
Q4 24
$-0.03
$1.27
Q3 24
$-1.48
$1.41
Q2 24
$-0.65
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
SRCE
SRCE
Cash + ST InvestmentsLiquidity on hand
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$152.7M
$1.3B
Total Assets
$1.0B
$9.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
SRCE
SRCE
Q1 26
Q4 25
$583.8M
Q3 25
$565.2M
Q2 25
$545.5M
Q1 25
$520.6M
Q4 24
$535.6M
Q3 24
$522.0M
Q2 24
$561.5M
Stockholders' Equity
IRTC
IRTC
SRCE
SRCE
Q1 26
$1.3B
Q4 25
$152.7M
$1.3B
Q3 25
$121.9M
$1.2B
Q2 25
$103.7M
$1.2B
Q1 25
$86.7M
$1.2B
Q4 24
$90.9M
$1.1B
Q3 24
$71.8M
$1.1B
Q2 24
$99.2M
$1.0B
Total Assets
IRTC
IRTC
SRCE
SRCE
Q1 26
$9.1B
Q4 25
$1.0B
$9.1B
Q3 25
$995.2M
$9.1B
Q2 25
$964.0M
$9.1B
Q1 25
$926.1M
$9.0B
Q4 24
$931.4M
$8.9B
Q3 24
$909.7M
$8.8B
Q2 24
$919.2M
$8.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
SRCE
SRCE
Operating Cash FlowLast quarter
$26.2M
$59.1M
Free Cash FlowOCF − Capex
$14.5M
$58.1M
FCF MarginFCF / Revenue
6.9%
51.4%
Capex IntensityCapex / Revenue
5.6%
0.9%
Cash ConversionOCF / Net Profit
4.70×
1.48×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$361.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
SRCE
SRCE
Q1 26
$59.1M
Q4 25
$26.2M
$223.1M
Q3 25
$34.9M
$51.0M
Q2 25
$27.7M
$44.9M
Q1 25
$-7.9M
$71.8M
Q4 24
$19.2M
$193.9M
Q3 24
$24.3M
$68.4M
Q2 24
$11.8M
$50.0M
Free Cash Flow
IRTC
IRTC
SRCE
SRCE
Q1 26
$58.1M
Q4 25
$14.5M
$213.0M
Q3 25
$20.1M
$47.3M
Q2 25
$17.3M
$43.0M
Q1 25
$-17.3M
$69.3M
Q4 24
$12.4M
$181.5M
Q3 24
$15.5M
$66.7M
Q2 24
$3.4M
$46.4M
FCF Margin
IRTC
IRTC
SRCE
SRCE
Q1 26
51.4%
Q4 25
6.9%
192.2%
Q3 25
10.4%
42.7%
Q2 25
9.3%
39.8%
Q1 25
-10.9%
66.6%
Q4 24
7.5%
185.5%
Q3 24
10.5%
68.1%
Q2 24
2.3%
47.7%
Capex Intensity
IRTC
IRTC
SRCE
SRCE
Q1 26
0.9%
Q4 25
5.6%
9.1%
Q3 25
7.7%
3.4%
Q2 25
5.6%
1.7%
Q1 25
5.9%
2.4%
Q4 24
4.2%
12.6%
Q3 24
6.0%
1.7%
Q2 24
5.7%
3.7%
Cash Conversion
IRTC
IRTC
SRCE
SRCE
Q1 26
1.48×
Q4 25
4.70×
5.42×
Q3 25
1.21×
Q2 25
1.20×
Q1 25
1.91×
Q4 24
6.17×
Q3 24
1.96×
Q2 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

SRCE
SRCE

Segment breakdown not available.

Related Comparisons